Why exhibit at CPhI Japan?Japan’s pharmaceutical industry is a pro-innovative marketplace with total sales expected to rise to $80 billion by 2012. The regulatory barriers that traditionally shaped the Japanese pharmaceutical market over the last 10 years have started to come down; as a result the future offers major growth prospects for pharmaceutical businesses. The opening up of the generic market, strongly supported by the government, patent expiries and the largely un-penetrated nature of the market are all contributing factors towards its growth.
To make sure that your organisation is represented, call our team today at +31 20 40 99 505 or click here for information how to book your stand. |
| |||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||